Biotech: Why It’s Not a Bubble
March 31, 2015 at 10:54 AM EDT
Barclays’ Geoff Meacham explains why he doesn’t think biotech stocks like Biogen Idec (BIIB) and Gilead Sciences (GILD) are in bubble territory: Bloomberg News Our industry view is still positive; fundamentally, we believe that biotech is still in the early innings of an innovation cycle, but one could argue that valuations (more in SMId than [...]
